These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27859761)

  • 21. Relapse to opioid use in opioid-dependent individuals released from compulsory drug detention centres compared with those from voluntary methadone treatment centres in Malaysia: a two-arm, prospective observational study.
    Wegman MP; Altice FL; Kaur S; Rajandaran V; Osornprasop S; Wilson D; Wilson DP; Kamarulzaman A
    Lancet Glob Health; 2017 Feb; 5(2):e198-e207. PubMed ID: 27964869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?
    Srivastava A; Kahan M; Nader M
    Can Fam Physician; 2017 Mar; 63(3):200-205. PubMed ID: 28292795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed villous maturation in term placentas exposed to opioid maintenance therapy: a retrospective cohort study.
    Serra AE; Lemon LS; Mokhtari NB; Parks WT; Catov JM; Venkataramanan R; Caritis SN
    Am J Obstet Gynecol; 2017 Apr; 216(4):418.e1-418.e5. PubMed ID: 28024988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.
    Jordan CJ; Cao J; Newman AH; Xi ZX
    Neuropharmacology; 2019 Nov; 158():107609. PubMed ID: 31009632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Buprenorphine for managing opioid withdrawal.
    Gowing L; Ali R; White JM; Mbewe D
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD002025. PubMed ID: 28220474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.
    Soyka M; Kranzler HR; van den Brink W; Krystal J; Möller HJ; Kasper S;
    World J Biol Psychiatry; 2011 Apr; 12(3):160-87. PubMed ID: 21486104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supervised dosing with a long-acting opioid medication in the management of opioid dependence.
    Saulle R; Vecchi S; Gowing L
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011983. PubMed ID: 28447766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Pharmacological Treatments for Opioid Use Disorder on Mortality.
    Kelty E; Hulse G; Joyce D; Preen DB
    CNS Drugs; 2020 Jun; 34(6):629-642. PubMed ID: 32215842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
    Maas J; Barton G; Maskrey V; Pinto H; Holland R
    Drug Alcohol Depend; 2013 Dec; 133(2):494-501. PubMed ID: 23962419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Breen C; Kimber J; Davoli M
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD002207. PubMed ID: 24500948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of blood toxicology in fatalities involving alcohol and other drugs in patients with an opioid use disorder treated with methadone, buprenorphine, and implant naltrexone.
    Kelty E; Hulse G; Joyce D
    Am J Drug Alcohol Abuse; 2020; 46(2):241-250. PubMed ID: 31860367
    [No Abstract]   [Full Text] [Related]  

  • 32. Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.
    Curcio F; Franco T; Topa M; Baldassarre C;
    Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):871-4. PubMed ID: 21845796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal abstinence syndrome after methadone or buprenorphine exposure.
    Jones HE; Kaltenbach K; Heil SH; Stine SM; Coyle MG; Arria AM; O'Grady KE; Selby P; Martin PR; Fischer G
    N Engl J Med; 2010 Dec; 363(24):2320-31. PubMed ID: 21142534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol.
    Dennis BB; Naji L; Bawor M; Bonner A; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Samaan Z; Thabane L
    Syst Rev; 2014 Sep; 3():105. PubMed ID: 25239213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Methadone Treatment in Malaysia: Findings from the Malaysian Methadone Treatment Outcome Study (MyTOS).
    Ali N; Aziz SA; Nordin S; Mi NC; Abdullah N; Paranthaman V; Mahmud M; Yee A; Danaee M
    Subst Use Misuse; 2018 Jan; 53(2):239-248. PubMed ID: 29116878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methadone Medical Maintenance: An Early 21st-Century Perspective.
    Novick DM; Salsitz EA; Joseph H; Kreek MJ
    J Addict Dis; 2015; 34(2-3):226-37. PubMed ID: 26110221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benzodiazepine Use in Opioid Maintenance Treatment Programme: Risks and Clinical Outcomes.
    Oliveira C; Filipe R; Meira J; Sampaio L; Teixeira L; Rodrigues J; Nunes I; Tavares J
    Acta Med Port; 2021 Mar; 34(3):209-216. PubMed ID: 33971116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Constipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatment.
    Haber PS; Elsayed M; Espinoza D; Lintzeris N; Veillard AS; Hallinan R
    Drug Alcohol Depend; 2017 Dec; 181():132-139. PubMed ID: 29054032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities.
    Johnson B; Richert T
    Harm Reduct J; 2019 May; 16(1):31. PubMed ID: 31046774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 12-month evaluation of health-related quality of life outcomes of methadone maintenance program in a rural Malaysian sample.
    Lua PL; Talib NS
    Subst Use Misuse; 2012 Aug; 47(10):1100-5. PubMed ID: 22545914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.